The Chitosan Market size is projected to reach US$ 7.06 billion by 2031 from US$ 2.95 billion in 2023. The market is expected to register a CAGR of 11.5% in 2023–2031. Chitosan—a linear polysaccharide composed of randomly distributed beta-(1-4)-linked D-glucosamine and N-acetyl-D-glucosamine units, obtained by deacetylation of chitin extracted primarily from crustacean exoskeletons—serves as a versatile, biocompatible, and biodegradable biopolymer engineered to deliver exceptional antimicrobial, film-forming, coagulating, and wound-healing properties across biomedical, pharmaceutical, water treatment, and agricultural sectors.

The rapid expansion of the global chitosan market is primarily propelled by the surging global demand for eco-friendly, bio-based materials, stringent environmental regulations governing municipal and industrial wastewater treatment, and expanding applications in advanced wound care and drug delivery systems. As industries worldwide prioritize sustainable circular economy solutions and biocompatible polymers that reduce reliance on petroleum-based plastics, chitosan has emerged as an indispensable functional biopolymer.

Download Exclusive Sample Chitosan Market Study- https://www.theinsightpartners.com/sample/TIPRE00004218

What is driving the market?

The primary growth driver for the chitosan market is the escalating demand for high-performance natural coagulants and flocculants in wastewater treatment plants. Because chitosan possesses cationic properties that effectively bind negatively charged suspended solids, heavy metals, and organic pollutants, municipal and industrial water treatment facilities increasingly rely on it to purify effluent streams without introducing toxic synthetic residues.

Additionally, burgeoning applications in agriculture (as a seed coating, biopesticide, and plant growth stimulator), wound-healing dressings, drug delivery nanoparticles, and functional cosmetics heavily accelerate market consumption. The market also benefits from continuous technological breakthroughs in enzymatic deacetylation, medical-grade purity refinement, and chitosan-based hydrogel engineering. However, inconsistent crustacean waste feedstock supply, high processing costs for ultra-pure biomedical grades, and complex regulatory approvals for medical devices remain key challenges for broader commercial expansion.

Which segment leads?

By grade, Industrial and Water Treatment Grade chitosan commands the dominant market share due to its massive volume consumption in municipal wastewater purification, heavy metal removal, and agricultural soil conditioning. Biomedical and Pharmaceutical Grade chitosan represents a key high-value segment prized for its strict purity, biocompatibility, and clinical efficacy in wound management and drug delivery.

By application, Water Treatment leads in overall revenue share, driven by strict regulatory requirements for industrial effluent cleanup and municipal water purification. Biomedical & Pharmaceuticals, Agriculture, Food & Beverages, and Cosmetics & Personal Care represent core commercial end-use markets.

Which companies are prominent?

The report profiles industry participants, including KitoSano SL, Advanced Biopolymers AS, FMC Corporation, GTC Bio Corporation, Golden-Shell Pharmaceuticals, Heppe Medical Chitosan GmbH, Panvo Organics Pvt Ltd, Primex EHF, Qingdao Yunzhou Biochemistry Co Ltd, Kitozyme LLC, NovaMatrix, France Chitin, TerraVerdae Bioworks, Yixing Cleanwater Chemicals Co Ltd, and ChitoLytic, while analyzing competitive strategies and innovation developments.

Prominent market participants focus on scaling up non-animal-derived chitosan production (utilizing fungal fermentation sources), expanding medical-grade purification capacities, and securing consistent crustacean waste feedstock agreements. Strategic differentiation relies on delivering tightly controlled molecular weight specifications, high deacetylation degrees, and comprehensive regulatory compliance documentation for pharmaceutical clients.

Buy Complete Report: https://www.theinsightpartners.com/buy/TIPRE00004218

Frequently Asked Questions (FAQ)

1. What is the projected market size and CAGR for the Chitosan Market?

The Chitosan Market size is projected to reach US$ 7.06 billion by 2031 from US$ 2.95 billion in 2023, registering a CAGR of 11.5% during 2023–2031.

2. What are the key growth drivers for the Chitosan Market?

Key growth drivers include rising demand for natural coagulants in wastewater treatment, expanding applications in wound care and drug delivery, agricultural biopesticide use, and the global shift toward bio-based polymers.

3. Why do industrial and water treatment applications dominate chitosan consumption?

Industrial applications account for the vast majority of volume due to chitosan’s exceptional efficacy as a cationic flocculant in removing suspended solids, organic pollutants, and heavy metals from wastewater.

4. How are industry participants addressing feedstock and purity challenges?

Manufacturers are actively developing fungal-derived chitosan alternatives to avoid crustacean allergen and supply limitations, alongside investing in advanced chromatographic purification to achieve medical-grade standards.

About Us

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients find precise solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Chemicals and Materials, Biotechnology, Pharmaceuticals, Water Treatment, and Specialized Industrial Manufacturing.

Contact Us

If you have any queries about this comprehensive market report or would like to request further details, please reach out to our team:

• Contact Person: Sameer Joshi

• E-mail: sales@theinsightpartners.com

• Phone: +1-646-491-9876

• Website: www.theinsightpartners.com

• Also Available in :
  KoreanGermanJapaneseFrenchChineseItalianSpanish